Huiwen Yan

8PUBLICATIONS
8CO-AUTHORS
Innate immunityHaematological tumoursTraditional Chinese medicine and treatmentsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 25, 2025
Based on Soluble Immune Checkpoints Constructing a Random Survival Forest Model to Predict the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Xue Cai, Lihua Yu, Xiaoli Liu

|Mar 10, 2025
FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription.

Yuqing Xie, Fengna Yan, Xiaoli Liu

|Jun 17, 2024
Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus-Atractylodes Herb Pair in Treating Hepatocellular Carcinoma.

Yuling Liang, Yuqing Xie, Xiaoli Liu

|Jun 12, 2024
Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.

Wanxin Shi, Huiwen Yan, Xiaoli Liu

|Sep 27, 2023
A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age.

Yuan Wu, Xiaoli Liu, Xinhui Wang

|Jan 11, 2023
The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma.

Lihua Yu, Lei Sun, Xiaoli Liu

Pageof 2

Frequent Collaborators

8 joint publications

Zhiyun Yang

7 joint publications

Zhiyun Yang

4 joint publications

Yuan Wu

3 joint publications

Xinhui Wang